Therefore, VEGF likely plays a central role in the vicious cycle of CHD-T2D comorbidity by coordinating abnormal vascular permeability (exacerbating lipid infiltration/inflammation), pathological neovascularization, and dysregulated fatty acid transport. This evidence concerns the gene VEGFA and type 2 diabetes mellitus.